These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7504384)

  • 1. [Biological properties and clinical application of filgrastim (G-CSF)].
    Robak T; Krykowski E
    Acta Haematol Pol; 1993; 24(3):239-51. PubMed ID: 7504384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C; Coleman DL
    Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions.
    Hollingshead LM; Goa KL
    Drugs; 1991 Aug; 42(2):300-30. PubMed ID: 1717226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biologic aspects and clinical use of granulocyte growth factor].
    Rupoli S; Battelli N; Del Prete S; Salvi A; Cinciripini A; Scortechini AR; Cantori I; Barulli S; Leoni P
    Recenti Prog Med; 1995 Dec; 86(12):510-7. PubMed ID: 8588087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effects of biologic response modifiers.
    Louie SG; Jung B
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S10-8. PubMed ID: 7689788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human granulocyte colony-stimulating factor (G-CSF), the premier granulopoietin: biology, clinical utility, and receptor structure and function.
    Tkatch LS; Tweardy DJ
    Lymphokine Cytokine Res; 1993 Dec; 12(6):477-88. PubMed ID: 7510132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte colony stimulating factor.
    Nguyen YK
    J Fla Med Assoc; 1994 Jul; 81(7):467-9. PubMed ID: 7525857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost considerations in therapy with myeloid growth factors.
    Glaspy JA; Jakway J
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S19-26. PubMed ID: 7689789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies of granulocyte colony stimulating factor (G-CSF).
    Scarffe JH; Kamthan A
    Cancer Surv; 1990; 9(1):115-30. PubMed ID: 1703454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic administration of granulocyte colony-stimulating factor (filgrastim) after conventional chemotherapy in children with cancer.
    Riikonen P; Rahiala J; Salonvaara M; Perkkiö M
    Stem Cells; 1995 May; 13(3):289-94. PubMed ID: 7542114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.
    Grigg A; Begley CG; Juttner CA; Szer J; To LB; Maher D; McGrath KM; Morstyn G; Fox RM; Sheridan WP
    Bone Marrow Transplant; 1993; 11 Suppl 2():23-9. PubMed ID: 8334435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the efficacy and tolerability of recombinant haematopoietic growth factors in bone marrow transplantation.
    Barge AJ
    Bone Marrow Transplant; 1993; 11 Suppl 2():1-11. PubMed ID: 8334433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of recombinant human colony-stimulating factors.
    Klingemann HG
    CMAJ; 1989 Jan; 140(2):137-42. PubMed ID: 2642725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor).
    Sonoda Y; Ohno Y; Fujii H; Takahashi T; Nakayama S; Haruyama H; Nasu K; Shimazaki C; Hara H; Kanamaru A
    Stem Cells; 1993 Nov; 11(6):543-54. PubMed ID: 7509223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant human granulocyte colony-stimulating factor (G-CSF)].
    Ariyoshi Y
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):541-9. PubMed ID: 7680849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical utility of granulocyte colony-stimulating factor: early achievements and future promise.
    Morstyn G; Foote M; Perkins D; Vincent M
    Stem Cells; 1994; 12 Suppl 1():213-27; discussion 227-8. PubMed ID: 7535147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with metastatic breast cancer.
    Kennedy MJ; Davis J; Passos-Coelho J; Noga SJ; Huelskamp AM; Ohly K; Davidson NE
    Cancer Res; 1993 Nov; 53(22):5424-8. PubMed ID: 7693341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
    Schmitz N; Dreger P; Zander AR; Ehninger G; Wandt H; Fauser AA; Kolb HJ; Zumsprekel A; Martin A; Hecht T
    Bone Marrow Transplant; 1995 Feb; 15(2):261-6. PubMed ID: 7539668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.